0001526465-19-000001.txt : 20191031 0001526465-19-000001.hdr.sgml : 20191031 20191031150835 ACCESSION NUMBER: 0001526465-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191031 DATE AS OF CHANGE: 20191031 EFFECTIVENESS DATE: 20191031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hapten Sciences, Inc. CENTRAL INDEX KEY: 0001526465 IRS NUMBER: 452788415 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352299 FILM NUMBER: 191183388 BUSINESS ADDRESS: STREET 1: 40 S. MAIN, SUITE 2300 CITY: MEMPHIS STATE: TN ZIP: 38103 BUSINESS PHONE: 9017473946 MAIL ADDRESS: STREET 1: 40 S. MAIN, SUITE 2300 CITY: MEMPHIS STATE: TN ZIP: 38103 D 1 primary_doc.xml X0708 D LIVE 0001526465 Hapten Sciences, Inc. 40 S. MAIN, SUITE 2200 MEMPHIS TN TENNESSEE 38103 9017473946 DELAWARE None None Corporation true Gary Prosterman 40 South Main Street Suite 2200 Memphis TN TENNESSEE 38103 Executive Officer Director Raymond J. Hage 40 South Main Street Suite 2200 Memphis TN TENNESSEE 38103 Executive Officer Director Stephen L. Bandak 40 South Main Street Suite 2200 Memphis TN TENNESSEE 38103 Director Gary Stevenson 40 South Main Street Suite 2200 Memphis TN TENNESSEE 38103 Director Pharmaceuticals Decline to Disclose 06b false 2019-10-21 false true true true Convertible Promissory Note false 0 1500000 885980 614020 false 4 0 0 0 false Hapten Sciences, Inc. /s/ Raymond Hage Raymond Hage CEO 2019-10-31